您的位置: 首页 > 农业专利 > 详情页

鑒定I類MHC相關的糖肽作為癌症免疫療法的靶標
专利权人:
UNIVERSITY OF VIRGINIA PATENT FOUNDATION;THE UNIVERSITY OF BIRMINGHAM
发明人:
HUNT, Donald, F.,SHABANOWITZ, Jeffrey,MALAKER, Stacy, A.,COBBOLD, Mark,PENNY, Sarah
申请号:
HK18115747
公开号:
HK1256615A1
申请日:
2018.12.10
申请国别(地区):
HK
年份:
2019
代理人:
摘要:
Provided are compositions that include one or more peptides, wherein each peptide is at least 8 amino acids long and has an amino acid sequence as set forth in any of SEQ ID NOs: 1-45. Also provided are in vitro populations of dendritic cells that include the disclosed compositions, in vitro populations of CD8+ T cells capable of being activated upon being brought into contact with the disclosed populations of dendritic cells, antibodies or antibody-like molecules that specifically bind to complexes of MHC class I molecules and the disclosed peptides, methods for treating and/or preventing cancer such as leukemia using the disclosed compositions and/or populations, methods for making cancer vaccines using the disclosed compositions, methods for screening target peptides for inclusion in an immunotherapy composition, methods for determining a prognosis of a leukemia patient, and kits that include at least one of the disclosed peptides.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充